Delivery Order SPE2DB20D2104-SPE2DB23FU57K

Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,931.70 firm fixed-price delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,705.56 firm-fixed-price delivery order is for the supply of BRILINTA 60 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of November 15, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $2,206.07 delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a firm fixed price and is set to be completed by March 20, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,961.38 delivery order contract is for the supply of Brilinta 90 mg tablets, a cardiovascular medication. The contract has a firm fixed price pricing type and a completion date of November 16, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,697.53 firm fixed-price contract is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. This contract is not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,680.55 Firm Fixed Price Delivery Order is for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The award has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of BRILINTA 60 MG TABLET 60S. The $1,086.68 firm fixed-price delivery order has a completion date of July 27, 2023 and was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order with a ceiling value of $3,564.00 for the supply of BRILINTA 90 MG TABLET 60S. The award was issued by the Defense Logistics Agency (DLA), a major procurement arm of the Department of Defense (DoD), and has an ultimate completion date of December 13, 2022. Amerisourcebergen, a prominent pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,841.30 firm fixed-price delivery order is for BRILINTA 60 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,069.60 for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FU57K
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,572.60 firm fixed-price delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of July 27, 2023.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable the efficient procurement of essential pharmaceutical and medical items to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:59 AM